None listed
Conditions
Brief summary
Community rehabilitation after stroke may be limited due to factors as difficulties getting to appointments and limited access. Telerehabilitation, delivery of rehabilitation through communication technologies has emerged as a promising platform, and may overcome many of these difficulties. The primary aim of the pilot Randomized Controlled Trial (RCT) is to determine the effect of home-delivered telerehabilitation on physical activity compared with centre-based community rehabilitation in people with stroke with matched scheduled therapy time across both interventions. We hypothesize that people with stroke who receive home-delivered telerehabilitation will demonstrate 1) Increased daily physical activity and 2) better clinical, patient related and economic outcomes when compared with those receiving centre-based community rehabilitation.
Interventions
2 cohorts: Participants will be randomised to a home-delivered telerehabilitation or centre-based community rehabilitation cohort. Participants will receive 6 weeks of rehabilitation delivered over a 6-8 weeks period. Both groups will receive the same amount of total scheduled therapy time related to physical activity: Totaling 2 hours of Physiotherapy and/or Occupational Therapy time and 2 hours of Allied Health Assistant therapy time per week. Both intervention arms will provide individually tailored task-specific exercises targeting physical activity. In addition, both intervention arms will coach, educate and mentor participants in self-managing their physical activities in daily life. Further, both interventions will use patient specific goal setting and follow therapy recommendations as outlined by the Australian Stroke National Guidelines. The need for physiotherapy or occupational therapy, including duration of sessions will be determined based on how participants can best achieve their specific goals. Intervention administration: Participants randomised to home-delivered telerehabilitation will receive rehabilitation delivered at their residential address through a technology device e.g. tablet, computer. Participants will receive 2 hours rehabilitation from a physiotherapist and/or occupational therapist and 2 hours of rehabilitation delivered from an Allied Health Assistant per week. Participants randomised to centre-based community rehabilitation will travel to their nearest centre for rehabilitation. Patient will receive 2 hours rehabilitation from a physiotherapist and/or occupational therapist and 2 hours of rehabilitation delivered from an Allied Health Assistant per week. Mode of therapy administration: Participants randomised to home-delivered telerehabilitation will receive rehabilitation delivered through a technology device. Participants randomised to centre-based rehabilitation will be delivered in a one-on-one or/and in a group session (max 8 people). All aspects of the delivered therapy will be monitored and recorded: Service delivery fidelity 1) Start and end time of intervention session 2) Health professional involved (PT/OT or AHA) 3) Frequency of sessions/ total sessions 4) Attendance/ cancelled/ did not attend/ rescheduled (includes reason technology failures) 5) Caregiver attendance Y/N – Caregiver presence required Y/N Therapy content fidelity 1) Content of sessions in ‘active minutes’ spent on physical activity 2) Content of sessions in minutes on rest, self-management, education, goal setting, documentation, and other non-patient contact time. 3) Time to set up session
Sponsors
Study design
Eligibility
Inclusion criteria
>18 years of age First or recurrent stroke (ischemic and hemorrhagic) A modified Rankin Scale (mRS) of 1, 2, 3 or 4 on discharge from hospital (acute or subacute inpatient) Presence of motor impairments Able to engage in rehabilitation through information technology Own technology device (or loan tablet) and data plan to support telerehabilitation Able to sign consent or has a substitute decision maker who can sign consent (pending governance approvals for substitute decision maker consent from QCAT)
Exclusion criteria
Premorbid mRS>3 Concurrent progressive neurologic disorder including severe dementia End-stage medical/ palliative conditions with life expectancy <6 months Severe aphasia (unable to follow one stage commands)